Mesa Laboratories (MLAB) Notes Payables (2011 - 2026)
Mesa Laboratories' (MLAB) quarterly Notes Payables came in at $77.2 million in Q2 2026, down 8.58% quarter-over-quarter from $84.5 million in Q1 2026.
Analysis
Mesa Laboratories (MLAB) Notes Payables (2011 - 2026) Analysis & Trends
Mesa Laboratories has disclosed Notes Payables across 2 years of filings, most recently posting $77.2 million for Q2 2026.
- In Q2 2026, Notes Payables changed N/A year-over-year to $77.2 million; the TTM figure through Jun 2026 stood at $77.2 million (changed N/A YoY), while the FY2026 annual figure was $84.5 million, changed N/A from the prior year.
- Notes Payables came in at $77.2 million for Q2 2026 at Mesa Laboratories, down from $84.5 million in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $84.5 million in Q1 2026 to a low of $77.2 million in Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 223.99 Bn | 219.93 Bn | 8.34 Bn |
| 2 | Danaher | 141.56 Bn | 137.22 Bn | 3.61 Bn |
| 3 | Agilent Technologies | 40.36 Bn | 38.60 Bn | 1.04 Bn |
| 4 | Illumina | 30.41 Bn | 29.24 Bn | 770.00 Mn |
| 5 | Revvity | 13.50 Bn | 12.48 Bn | 416.87 Mn |
| 6 | Bio-Techne | 11.25 Bn | 10.98 Bn | 211.39 Mn |
| 7 | Bio-Rad Laboratories | 9.88 Bn | 8.26 Bn | 345.80 Mn |
| 8 | Repligen | 9.29 Bn | 8.28 Bn | 110.04 Mn |
| 9 | 10x Genomics | 8.62 Bn | 8.06 Bn | 112.50 Mn |
| 10 | Mesa Laboratories | 684.72 Mn | 652.49 Mn | 39.01 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 77.25 Mn |
| Mar 31, 2026 | 84.50 Mn |
| Sep 30, 2011 | 1.00 Mn |
| Jun 30, 2011 | 1.00 Mn |
| Mar 31, 2011 | 600,000.00 |